chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx. 1 min. after vaccine given, localized reaction appeared at RUT injection site. Very erythematous, tender to touch and swelled. Inconsolable at the present time. PA consulted, child able to bear weight. Dr consulted and reassured Mom. Tylenol 160mg administered. Ice applied to injection site, for about 10 min. Mom then got pt dressed and she calmed down and stopped crying. Pt. left the office in satisfactory condition.
On 10/19/2022 at 8:00AM I had a headache, cough, runny nose, and congestion.  On 10/13/2022 and 10/18/2022 I did 2  home COVID-19 tests which were negative. On 10/19/2022 I did another home COVID-19 test which was positive.  I did a telehealth visit with my doctor on 10/19/2022. She prescribed me Albuterol as needed and Paxlovid for 5 days.
The day after dose #1 of Moderna the left deltoid was red, hard, and raised approximately 2 - 2 1/2 inches in diameter. Reported 7 days after vaccination and still erythematous. Advised Ibuprofen and cold packs.
First COVID vaccine was Pfizer. Second COVID vaccine is unclear whether Pfizer or Moderna was given. No adverse reactions.
1 of 4 pts vaxed from the same vial who had an adverse event;pt exp erythema & swelling from the shoulder to elbow of vaxed arm;seen by MD dx cellulitis;(no cultures done);rx w/ATB
Joint pain and stiffness after resting arm for awhile. The shot was administered directly under acromion process, not 2-3 finger widths down. No treatment sought, yet. Waiting to see if there is improvement over time. Taking ibuprofen at night to sleep. Pain is the not improving five days later.
pt recvd vax for prophylaxis; exp red raised rash on both arms,leg & on chest/back;resolved;
This is a cluster of 2 patients who experienced adverse events following administration of FLUZONE Intradermal (UT4163AA). The events for the other patient was captured in case number 2011-09894. Initial report was received on 11 October 2011 from a healthcare provider. A 61-year-old female patient had received FLUZONE Intradermal; lot number UT4163AA in left arm on 05 October 2011. On the same day within two in half to three hours, the patient developed a dime sized area of redness in between her fourth and fifth fingers and itchiness on left hand. No further informational was available at the time of the report. The patient's outcome was reported as unknown. Follow-up information was received from a healthcare professional on 03 January 2012. No additional information at this time. The patient outcome was reported as recovered/resolved on 11 October 2011. Documents held by sender: none.
Hematoma, inflammation, swelling, pain and tenderness on right (aprox. 5" circunferente). Extended to inside of the upper arm. Small lesion (1 mm) on the site of administration. Patient referred difficulty to lift the arm (aporx 40%).  Patient have been taking acetaminophen and ice on administration site during the last 3 days.
Tested positive/ appear to be asymptomatic; Tested positive/ appear to be asymptomatic; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 31Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 62 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "obesity" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL. The following information was reported: DRUG INEFFECTIVE (medically significant), ASYMPTOMATIC COVID-19 (medically significant) all with onset 19Jul2022, outcome "not recovered" and all described as "Tested positive/ appear to be asymptomatic". The patient underwent the following laboratory tests: SARS-CoV-2 test: (19Jul2022) Positive, notes: Tested positive on 19Jul2022; (31Jul2022) Negative, notes: and tested negative by the following Sunday; (07Aug2022) Positive, notes: I tested positive again on 07Aug2022. Therapeutic measures were taken as a result of drug ineffective, asymptomatic covid-19. Additional information: Tested positive on 19Jul2022 and started Paxlovid for 5 days from 21Jul2022 to 25Jul2022 and tested negative by the following Sunday. Then, I tested positive again on 07Aug2022. I appear to be asymptomatic, but I tested because my husband also tested positive one day before me. Patient has no known allergy.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
No adverse event; A nurse reported that an improperly stored dose of ROTATEQ was administered to a patient; This spontaneous report was received from a registered nurse and refers to a 4-month-old patient of unknown gender. The patient's concurrent conditions, medical history, allergies and concomitant therapies were not reported.  On 01-AUG-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (1 dose [DS] x 10 tubes) oral liquid, lot #U037812, expiration date: 29-MAR-2023, administered for prophylaxis (product storage error). No adverse event was reported.
Patient stated she was feeling light headed after standing up about 10 minutes after receiving flushot. Patient stated she may be feeling light headed due to working out prior to receiving flushot. Patient sat down for about 15 minutes after started feeling much better.
Migraines began 4/23-4/27, including visual auras. Have had mild chronic daily headaches every day since. NSAIDS have not been effective in eliminating pain. Have since stopped NSAIDS to eliminate possible rebound headaches- no change.
This spontaneous report was received from a non-pregnant female patient of unknown age referring to herself. There was no information about the patient's concurrent conditions, allergies or medical history provided. On unknown dates, the patient was vaccinated with an unspecified number of doses of M-M-R II (exact dose, route of administration, lot# and expiry date were not reported) for prophylaxis when she was a child. Other suspect therapies included sterile diluent. On an unknown date, reported as "recently", the patient was performed MMR titer drawn and the results showed a negative titer for rubella. The patient reported that she began treatment with "in vitro fertilization" on an unspecified date and she was not pregnant, and she also reported that she was undergoing treatment with "in vitro fertilization" at the reporting time. She sought medical attention (unspecified date). The outcome of the events was unknown. Causality assessment was not provided by the reporter.
Patient with 2 COVID vaccines who admitted with hematoma to leg, incidentally found positive on routine facility admission testing.  No hypoxia during stay.
It was reported that a pt 1 of 4 received a Rabies Imovax ID vaccination. Reportedly 24 hours following immunization the pt developed swelling of the arm, malaise and flu-like symptoms. Further information requested.
This case was reported by a healthcare professional and described the occurrence of fever in a 25-year-old female subject who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. On 26 November 2007 at 09:30, the subject inadvertently received 1st dose of Infanrix (.5 mL, left arm). No other vaccinations were received on 26 November 2007. On 26 November 2007, 12 hours after the vaccination with Infanrix, the subject experience fever, injection site pain, injection site redness, a little swelling injection site and wrong vaccine administered. The events were considered to be systemic due to the fever. The subject consulted a healthcare professional and required medical attention in the doctor's office. The subject was treated with an unspecified antipyretic. At the time of reporting the events were unresolved. The healthcare professional considered the events were probably related to vaccination with Infanrix.
This is an instance of breakthrough COVID-19 after which death occurred.   The individual was vaccinated with the Moderna product on 01/12/2021 and 02/09/2021.   They presented to emergency dept on 10/23/2021 via ambulance with primary complaint of assessment after a fall during which the individual's "right knee gave out and landed on the knee with the knee kind of twisted under [them]" There was concern for broken bone(s). Upon admission, they were noted to have a low-grade fever of 100 degrees F and low blood pressure. They were admitted and tested positive for COVID-19 on 10/23/2021. The individual was found to be in hypoxic respiratory failure and respiratory acidosis, and X-ray showed a femur fracture. The individual expressed wish to not be intubated. This wish was honored and the individual was transitioned to switch to end of life comfort care after discussion with family. The broken femur was not attempted to be corrected surgically. The individual remained hospitalized until their death on 10/26/2021.
Fever, flu, vomiting, aches, dizziness, heart racing, weakness of the body, shortness of breath
I started noticing when I would put my arm on the back of my chair that it started hurting. I rolled my sleeve up and my arm was red and swollen. I had a rash on my arm. It was on the whole upper part of my arm, should, and on to my chest a little bit. It lasted about four days. I called the doctor and they said it was normal. They told me to go to the hospital if I ever had difficulty breathing. I never started having difficulty breathing.
My left arm continues to throb on a daily basis ever since my flu vaccination. Sometimes the pain is so severe, it stops me dead in my tracks and the tears stream down my face because I can't find any relief for same. PLEASE HELP ME!!!!!!!!!!!!!!!!!!!!!!!!!!!
My tumor marker Chromogranin A elevated to 518; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 28Dec2020 (Batch/Lot number: unknown) at the age of 59 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "BRCA1" (unspecified if ongoing); "breast cancer" (unspecified if ongoing); "thyroid cancer" (unspecified if ongoing); "colon cancer" (unspecified if ongoing); "carcinoid cancer" (unspecified if ongoing); "Sulpha allergy" (unspecified if ongoing), notes: Known allergies: Sulfa. The patient took concomitant medications. The following information was reported: TUMOUR MARKER INCREASED (non-serious) with onset 06Jan2021, outcome "recovering", described as "My tumor marker Chromogranin A elevated to 518". The event "my tumor marker chromogranin a elevated to 518" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tumour marker increased.  Additional information: The patient was not pregnant at the time of vaccination. Other vaccine in four weeks was reported as no. Other medications in two weeks was reported as yes. No covid prior vaccination and covid tested post vaccination was reported as yes. Covid test type post vaccination was reported as unknown. It was reported that, her tumor marker Chromogranin A elevated to 518 7 days after 1st vaccine and further elevated to 648 within 2 weeks of second vaccine. Subsequent PET scan showed perihilar and mediastinal lymphadenopathy. Bronchoscopy with biopsy of nodes showed reactive lymphocytes. 3 months after vaccine, tumor marker still elevated but down to 125. Stated that, she had a history of carcinoid cancer but no active disease.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I got place in my arm like a 'kicked' placed; lumps under my arm; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 66-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was reported as EN6208, Expiry date was not reported) via an unspecified route of administration, administered on 12Mar2021 (at the age of 66-year-old) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date the reporter reported that, I got my shot Pfizer shot next day I got place in my arm like a 'kicked' placed, lumps under my arm. Patient received no treatment for the event. The outcome for the event was reported as unknown.   No follow-up attempts are possible. No further information is expected.
Face numbness; Headache; Fatigue; Legs aching; Muscle soreness in the left arm; Rapid heartbeat; This is a spontaneous report from a contactable health care patient.  This 40-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 11Jan2021 at single dose for COVID-19 immunisation. Vaccine location was left arm. Medical history included frequent migraines, anxiety and anemia. Historical vaccine included first dose of BNT162B2 (Lot # 1), intramuscular left arm, on 21Dec2020 at 07:30 AM for COVID-19 immunisation. Age at vaccination was 40-years-old for both doses. Concomitant medications included topiramate (TOPAMAX), ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE DAY VITAMINS), phentermine, phendimetrazine tartrate (BONTRIL), naproxen sodium (ALEVE), escitalopram. On 11Jan2021 at 12:00 PM, the patient experienced face numbness, headache, fatigue, legs aching, muscle soreness in the left arm, and rapid heartbeat. No treatment was received for the event. Outcome was recovering. Information on the lot/batch number has been requested.
Pain in left upper arm developed the day after 2nd COVID  vaccine on 1/22/21.  Persistent upper left arm pain, especially with internal rotation and abduction of shoulder. No redness, swelling, weakness, numbness or tingling.
Myalgia, Fever & NauseaVomiting Narrative: Employee states that symptoms did not start until the middle of the night after injection. States she woke up with "severe" arm pain, headache, dry mouth, nausea, body aches and fever. Highest noted to be 101.4
Patient received on 6/17/13 PENTACEL (R) arm Hep B (L) arm, she developed a rash the next day on face then progressed w/ welts to arms and legs w/ fever 103.
7 months post 2nd dose, I began to experience hair loss that has gotten progressively worse
Injection site soreness; Headache; General fatigue; This is a spontaneous report from a non-contactable consumer. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced injection site soreness, headache and general fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site soreness, headache and general fatigue was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Mom states the (L) arm that he received his Tdap in on 8-10-11 became fire red and hot on Fri and during weekend 8-12 Thru.
Pt. states that after receiving the 1st dose of Moderna 02/03/2021, started experiencing symptoms 08/2021 of Injection site itchiness with ?bump?. Primary visit 11/17/2021, referred to Dermatologist 11/29/2021 Biopsy preformed, 12/07/2021 Diagnosed with Sebaceous Cyst requiring surgery to remove. Pt. concerned with "Foreign Object" (Bandaid placed over injection site before injection) Dermatologist determined the Sebaceous Cyst developed due to a "Foreign Object" entering the skin. Pt. still experiencing symptoms.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 11-APR-2011, patient received improperly stored VARIVAX dose 2, from lot # 0552Z (expiry date not reported). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
I accidentally administered a double dose of HIB, no adverse events have been reported. Mother was contacted by physician.
Tingling mouth, swollen throat/tongue/face, difficulty breathing, confusion, hives.
Moderna COVID-19 Vaccine EUA.  Day 1 Mild discomfort pain at injection site Day 2-3  Soreness (pain), redness, swelling, minor itching Day 4 Mild discomfort pain at injection site Day 8 Mild itch and redness at injection site Day  9-11 Very itchy, upper arm swollen from injection site spreading outward, redness, injection site hard and inflamed (took acetaminophen, use ice pack) Day 12 is today- less swelling (still some) and mild itchiness
No issues at time of vaccination. On Jan 2, 2023 exhibited confusion and ultimately was not able to form any short term memories. Transported to local Hospital by ambulance.  Presented with sudden onset Transient Global Amnesia  TGA resolved in about 28 hours.  I have lost memory for the morning of the event, the event and nearly all details until the next day. Detailed health records are available upon request.
pt came in for appointment today and when i checked his chart this am i could not find one for him. Was told he needed the flu shot and the pt stated that he had not had a flu shot yet. pt got his flu shot right around 950am 3/5/22. advised provider and called pt and let him know that he did have a flu shot in october 2021 so he got an extra dose. provider stated there is nothing to worry about. pt stated understanding and had no further concerns. CDC was closed today will call tuesday when i am back in the office and do my report and vares then as well. Pt is aware I called the CDC tody they stated that getting an extra dose of the flu should not cause any serious problems just normal side effects that you would get when you get the flu shot.
lightheadedness Narrative: Vitals were taken Q4 hrs - symptoms resolved after 15 min
Fever lasting until 11/1/21 about 6pm Fatigue and body aches (ongoing, but improving) Swelling, heat, pain and redness on most of upper arm where injected (ongoing) Lower back pain lasting until 11/2/ 21 about 6am Fatigue (still ongoing) Chills lasting until 11/1/21 about 6pm Swelling and soreness of lymph nodes (ongoing) Symptoms managed with rest, hydration, ibuprofen, acetaminophen, Benadryl
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not reported. On 27-JUL-2016, the patient was vaccinated with an improperly stored PNEUMOVAX 23 (dose and route were unknown, lot # L050788, expiration date on 12-OCT-2017), which was exposed to temperature excursion of 49 degrees Fahrenheit (F) for 64 hours. There was no previous temperature excursion. Data logger was not involved. No symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
He woke up with a severe migraine, was kind of foggy. He felt like he had been poisoned. He was nauseous, spinning, and couldn't eat. He rode it out. It took 1 day to get back to normal.
Itching on right scapular area. Rash in scapula and axilla on right side appeared 1 day later. Rash is consistent with Zoster. Antiviral med prescribed.
Immediate numbness.  Inability to move arm within an hour.  Severe pain which led to ER visit evening of 3/8, pain and immobility continued (possible frozen shoulder).  Multiple doctors visits including Orthopedic Surgeon, Neurologist and general PC.  Have received Steroid shot, steroid taper and have been in Physical Therapy for 6 weeks. Pain is still severe and causes inability to fully use arm.
On 06/06/2002, pt states during the course of the day her hand grip became painful to her left arm and area right above the elbow. States it feels tender and has had this everyday including this day (?) reporting event 06/20/02, No bruises noted
Pt woke up on 2/17/02 with a few chickenpox lesions. By 2/18/02, has over 100 lesions all over body, head and extremities. Had Varivax on 8/25/95.
Painful  testicle; Swelling of testicle; A spontaneous report was received from a Consumer concerning of an unknown age, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events painful (Testicular pain) and swelling of the testicle (Testicular Swelling).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 29 Jan 2021, prior to the onset of the events the patient received the first of two planned doses of mRNA-1273 (Lot batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On the same day, the patient experienced the events painful and swelling of the testicle. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events,  painful, swelling of the testicle, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.